scispace - formally typeset
Open AccessJournal ArticleDOI

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

Reads0
Chats0
TLDR
This AASLD 2018 Hepatitis B Guidance provides a data-supported approach to screening, prevention, diagnosis, and clinical management of patients with hepatitis B.
About
This article is published in Hepatology.The article was published on 2018-04-01 and is currently open access. It has received 2399 citations till now. The article focuses on the topics: Hepatitis B & Mass screening.

read more

Citations
More filters
Journal ArticleDOI

Financial Compensation For Hepatologists in Different Practice Settings

TL;DR: It is concluded that hepatologists at LT centers are compensated at much higher rates per encounter than in other practice settings, due to salary subsidies provided by the UHLT and nonUHLT to their hepatologists.
Journal ArticleDOI

A critique and systematic review of the clinical utility of hepatitis B core-related antigen.

TL;DR: In this article , the authors performed a systematic review to determine the clinical utility of hepatitis B core-related antigen (HBcrAg) for chronic hepatitis B (CHB) using clinical trials, cohort studies, and case-control studies.
Journal ArticleDOI

Current Perspectives on Nucleos(t)ide Analogue Therapy for the Long-Term Treatment of Hepatitis B Virus

TL;DR: In this paper , the authors present updated recommendations for the optimal current treatment of choice with nucleos(t)ide analogues (NA) for chronic hepatitis B (CHB) infection.
Journal ArticleDOI

Real-world experience of switching from tenofovir disoproxil fumarate to tenofovir alafenamide in patients with chronic hepatitis B: a retrospective study

TL;DR: In this article, the effect of switching from TDF to TAF in patients with chronic hepatitis B (CHB) was analyzed using Friedman test with Dunn-Bonferroni post hoc tests and repeated-measures analysis of variance.
References
More filters
Journal ArticleDOI

Management of hepatocellular carcinoma.

TL;DR: The prevention of Cirrhosis can prevent the development of HCC and progression from chronic HCV infection to advanced fibrosis or cirrhosis may be prevented in 40% of patients who are sustained responders to new antiviral strategies, such as pegylated interferon and ribavirin.
Journal ArticleDOI

AASLD guidelines for the treatment of hepatocellular carcinoma

TL;DR: This paper aims to demonstrate the efforts towards in-situ applicability of EMMARM, as to provide real-time information about concrete mechanical properties such as E-modulus and compressive strength.
Journal ArticleDOI

Chronic hepatitis B: Update 2009

TL;DR: The 2009 update of the American Association for the Study of Liver Diseases (AASLD) Practice Guidelines for Management of Chronic Hepatitis B is now posted online at www.aasld.org, and the recommendation for first-line oral antiviral medications has been changed to tenofovir or entecavir, and adefovir has been moved to second-line Oral antiviral medication.
Journal ArticleDOI

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

TL;DR: More efficacious treatments, mass immunization programs, and safe injection techniques are essential for eliminating HBV infection and reducing global HBV‐related morbidity and mortality.
Related Papers (5)

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

Devin Razavi-Shearer, +195 more